S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

$5.58
-0.12 (-2.11%)
(As of 04/19/2024 ET)
Today's Range
$5.51
$5.68
50-Day Range
$5.53
$10.26
52-Week Range
$5.51
$14.37
Volume
563,701 shs
Average Volume
547,461 shs
Market Capitalization
$326.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.10

Health Catalyst MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.64 Rating Score
Upside/​Downside
116.8% Upside
$12.10 Price Target
Short Interest
Healthy
2.60% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
0.82mentions of Health Catalyst in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$12,251 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.47) to ($0.28) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.88 out of 5 stars

Medical Sector

26th out of 907 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

3rd out of 59 stocks

HCAT stock logo

About Health Catalyst Stock (NASDAQ:HCAT)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

HCAT Stock Price History

HCAT Stock News Headlines

Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
HCAT Dec 2024 10.000 put
Now Open: Crypto emergency update
During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.
HCAT Apr 2024 7.500 put
HCAT Apr 2024 10.000 call
HCAT Dec 2024 17.500 call
The 2024 Healthcare Analytics Summit (HAS) Kicks Off Today
Analyst Scoreboard: 5 Ratings For Health Catalyst
Q4 2023 Health Catalyst Inc Earnings Call
See More Headlines
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
4/21/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Computer programming, data processing, & other computer related
Sub-Industry
N/A
Current Symbol
NASDAQ:HCAT
Fax
N/A
Employees
1,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.10
High Stock Price Target
$16.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+116.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
11 Analysts

Profitability

Net Income
$-118,150,000.00
Pretax Margin
-39.80%

Debt

Sales & Book Value

Annual Sales
$295.94 million
Book Value
$6.38 per share

Miscellaneous

Free Float
56,982,000
Market Cap
$326.76 million
Optionable
Optionable
Beta
1.29
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives


HCAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings
or view top-rated stocks.

What is Health Catalyst's stock price target for 2024?

11 brokerages have issued twelve-month price targets for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they predict the company's share price to reach $12.10 in the next year. This suggests a possible upside of 116.8% from the stock's current price.
View analysts price targets for HCAT
or view top-rated stocks among Wall Street analysts.

How have HCAT shares performed in 2024?

Health Catalyst's stock was trading at $9.26 at the start of the year. Since then, HCAT stock has decreased by 39.7% and is now trading at $5.58.
View the best growth stocks for 2024 here
.

Are investors shorting Health Catalyst?

Health Catalyst saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 1,520,000 shares, a drop of 16.5% from the March 15th total of 1,820,000 shares. Based on an average trading volume of 617,600 shares, the days-to-cover ratio is presently 2.5 days.
View Health Catalyst's Short Interest
.

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our HCAT earnings forecast
.

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) released its quarterly earnings results on Thursday, February, 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The firm had revenue of $75.08 million for the quarter, compared to the consensus estimate of $73.67 million. Health Catalyst had a negative net margin of 39.92% and a negative trailing twelve-month return on equity of 12.19%.

What ETFs hold Health Catalyst's stock?

ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Robo Global Healthcare Technology and Innovation ETF (HTEC) and Fidelity Digital Health ETF (FDHT).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst updated its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).

When did Health Catalyst IPO?

Health Catalyst (HCAT) raised $129 million in an IPO on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include Nepsis Inc. (1.98%) and Los Angeles Capital Management LLC (0.10%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier.
View institutional ownership trends
.

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HCAT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners